Pulmonary Rehabilitation Study for Advanced Lung Cancer Survivors: Phase 2 Clinical Trial

Strategic Insights -

Researchers at the Case Comprehensive Cancer Center are conducting a Phase 2 clinical trial to investigate the effectiveness of pulmonary rehabilitation for advanced lung cancer survivors. The study aims to recruit 85 participants from the USA and involve collaboration with the United States Department of Defense. The trial has two parts: a randomized trial and an interview study, with the primary objective of understanding the benefits and challenges of pulmonary rehabilitation in improving functioning and reducing shortness of breath among participants.

Key Takeaways:

  • The trial is led by principal investigator Melinda Hsu, MD, MS, and is conducted in collaboration with the United States Department of Defense.
  • The study involves 85 participants from the USA who have previously been diagnosed with advanced stage non-small cell lung cancer (NSCLC).
  • Pulmonary rehabilitation is a type of supportive treatment that aims to improve symptoms such as fatigue, shortness of breath, and lower quality of life in NSCLC survivors.
  • The trial consists of a randomized trial and an interview study, with the purpose of understanding the benefits and challenges of pulmonary rehabilitation.
  • The study is currently not open for recruiting participants.

Statistics:

  • The trial aims to recruit 85 participants from the USA.
  • The study is a Phase 2 clinical trial.
  • The participants will be randomly assigned to either receive eight weeks of pulmonary rehabilitation or standard treatment.
  • The study has two parts: a randomized trial and an interview study.

Sources:

  • ClinicalTrials.gov: NCT07104630
  • Case Comprehensive Cancer Center: [Exact title not specified in the original text]
  • United States Department of Defense: [Exact title not specified in the original text]